Therapeutic Goods Amendment (Medicines Shortages and Other Measures) Bill 2026
Second ReadingSummary
This amendment to the Therapeutic Goods Act tackles medicine shortages in Australia by giving the government faster ways to approve alternative medicines and temporarily adjust supply requirements when stocks run low. When a critical medicine becomes hard to find, the changes let regulators quickly authorise substitutes or modified versions without the usual lengthy approval process, and allow companies to adjust how much they must keep on hand. For patients, this means less risk of running out of essential medications during supply disruptions, while for pharmaceutical companies it provides clearer rules about what flexibility they have when their usual products aren't available.
Bill Progress
Senate
First Reading
Second ReadingCurrent
Committee of the Whole
Third Reading
House of Representatives
First Reading
Second Reading
Consideration in Detail
Third Reading
Royal Assent
Royal Assent
What happens at this stage
The main debate on whether the chamber supports the broad purpose of the bill. Members speak to its overall merits and concerns rather than the fine print. The government outlines its policy intentions; the opposition and crossbench put their case. This is the stage that determines whether the bill proceeds at all.
Next: Consideration in Detail (House) or Committee of the Whole (Senate), where the bill is examined clause by clause